Cargando…

SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients

In patients with urinary magnesium wasting, oral and intravenous supplementation often fail to adequately improve serum magnesium levels. Glucose intolerance and diabetes mellitus frequently accompany hypomagnesemia. Clinical trials examining inhibitors of the type 2 sodium glucose cotransporter (SG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ray, Evan C., Boyd-Shiwarski, Cary R., Liu, Pengfei, Novacic, Danica, Cassiman, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380441/ https://www.ncbi.nlm.nih.gov/pubmed/32734255 http://dx.doi.org/10.1016/j.xkme.2020.01.010

Ejemplares similares

Case report: extreme coronary calcifications and hypomagnesemia in a patient with a 17q12 deletion involving HNF1B
por: Li, Howard J., et al.
Publicado: (2019)

Home Subcutaneous Magnesium Infusion in Refractory Hypomagnesemia: A Case Report
por: Tokarski, Rebecca M., et al.
Publicado: (2023)

SGLT2 Inhibitors in Management of Severe Hypomagnesemia in Patients Without Diabetes: A Report of 4 Cases
por: Shah, Chintan V., et al.
Publicado: (2023)

Hypomagnesemia-Induced Hypocalcemia Successfully Treated With Sodium-Glucose Cotransport Inhibitor (SGLT-2i), a Case Report
por: Gandhi, Anand, et al.
Publicado: (2021)

Sodium Glucose Co-Transporter2 (SGLT2) Inhibition for Refractory Hypomagnesemia in Monogenic Diabetes Type 5 (MODY 5)
por: Paul, Anju A, et al.
Publicado: (2021)

Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors
por: Kellon, Eleanor M., et al.
Publicado: (2023)

Pseudohypobicarbonatemia in a patient with amyloidosis
por: Bukhari, Marvi, et al.
Publicado: (2022)

Sodium-Glucose Cotransporter 2 Inhibitors and Management of Refractory Hypomagnesemia Without Overt Urinary Magnesium Wasting: A Report of 2 Cases
por: Shah, Chintan V., et al.
Publicado: (2022)

Familial Hypomagnesemia with Secondary Hypocalcemia Presenting as Refractory Seizures
por: Pandey, Amit Kumar, et al.
Publicado: (2023)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis
por: Kellon, Eleanor M., et al.
Publicado: (2022)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Famotidine induced hypomagnesemia leading to hypocalcemia
por: Essrani, Rajesh, et al.
Publicado: (2020)

Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature
por: Feng, Hao, et al.
Publicado: (2022)

Compounded Effervescent Magnesium for Familial Hypomagnesemia: A Case Report
por: Bennati, Giada, et al.
Publicado: (2023)

Hypomagnesemia because of nedaplatin for cervical cancer: A case report
por: Komoda, Jun, et al.
Publicado: (2023)

Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication
por: Semb, Synne, et al.
Publicado: (2017)

Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic
por: Uehara, Atsuko, et al.
Publicado: (2019)

Gitelman Syndrome Presenting with Hypomagnesemia, Hypokalemia and Hypocalciuria: A Case Report
por: Uzunlulu, Mehmet, et al.
Publicado: (2019)

Familial Hypomagnesemia, Hypercalciuria and Nephrocalcinosis with Novel Mutation
por: Margabandhu, S., et al.
Publicado: (2019)

Hypocalcemia secondary to hypomagnesemia in a patient on liraglutide
por: Habnouny, J.E.L., et al.
Publicado: (2020)

Hypertrophic Gastric folds with Hypomagnesemia, linking the dots
por: Zafar, Mansoor, et al.
Publicado: (2021)

Hypomagnesemia in Brachycephalic Dogs
por: Mellema, M.S., et al.
Publicado: (2014)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
por: Gao, Yuan, et al.
Publicado: (2021)

Cardiac Dysrhythmias and Neurological Dysregulation: Manifestations of Profound Hypomagnesemia
por: Mawri, Sagger, et al.
Publicado: (2017)

Dilemma in the emergency setting: hypomagnesemia mimicking acute stroke
por: Rico, María, et al.
Publicado: (2016)

Gitelman syndrome, hypomagnesemia, and venous thrombosis: An intriguing association
por: Chargui, Soumaya, et al.
Publicado: (2022)

Proton Pump Inhibitor-Induced Hypomagnesemia: A Rare, Potentially Fatal Complication
por: Pawlukiewicz, Alec J, et al.
Publicado: (2020)

SGLT-2 inhibitors and their potential in the treatment of diabetes
por: Rosenwasser, Rebecca F, et al.
Publicado: (2013)

Incidence of hypomagnesemia in the emergency room
por: Oliveira-Neto, PR, et al.
Publicado: (2003)

Hypomagnesemia: a clinical perspective
por: Pham, Phuong-Chi T, et al.
Publicado: (2014)

Prevention of Hypomagnesemia in Diabetes Patients
por: Madihi, Yahya, et al.
Publicado: (2013)

Hypomagnesemia in critically ill patients
por: Hansen, Bent-Are, et al.
Publicado: (2018)

Falls and SGLT-2 inhibitors in geriatric patients—A case report
por: Taşdemir, Anil, et al.
Publicado: (2020)

Posterior Reversible Encephalopathy Syndrome due to Hypomagnesemia: A Case Report and Literature Review
por: Almoussa, Mohamad, et al.
Publicado: (2018)

Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient
por: Bell, David S. H.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1if9s0b99a82grpk3ijg9h0sk1